Covalon Technologies (CVALF) to Release Earnings on Wednesday

Covalon Technologies (OTCMKTS:CVALF - Get Free Report) will likely be announcing its earnings results before the market opens on Wednesday, May 28th. Analysts expect the company to announce earnings of $0.01 per share and revenue of $7.67 million for the quarter.

Covalon Technologies (OTCMKTS:CVALF - Get Free Report) last posted its quarterly earnings data on Friday, February 21st. The company reported $0.03 EPS for the quarter, beating analysts' consensus estimates of ($0.03) by $0.06. Covalon Technologies had a net margin of 8.58% and a return on equity of 12.33%. The company had revenue of $5.84 million during the quarter, compared to analyst estimates of $6.37 million.

Covalon Technologies Price Performance

OTCMKTS CVALF traded up $0.03 on Friday, hitting $2.00. 5,015 shares of the stock were exchanged, compared to its average volume of 15,926. The company's 50-day moving average price is $1.72 and its two-hundred day moving average price is $2.06. The company has a market capitalization of $54.84 million, a price-to-earnings ratio of 28.58 and a beta of 0.49. Covalon Technologies has a 52-week low of $0.77 and a 52-week high of $3.08.

Covalon Technologies Company Profile

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company's platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity.